Search Results 91-100 of 1780 for ☃[카톡 BBR0119 텔레:ABK0119] 햇살론유스 햇살론유스 유스개인돈 긴급자금대출 즉시대출승인☃

  1. A Study to Evaluate the Effectiveness and Safety of Camidanlumab Tesirine (ADCT-301) in Patients with Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

    The purpose of this study is to evaluate the clinical effectiveness and safety of Camidanlumab Tesirine (ADCT-301) in participants with relapsed or refractory ...

  2. Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Estrogen Receptor Positive (ER+) Breast Cancer - Mayo Clinic

    This is a combination Phase I and Phase II study, with an aim to evaluate the combination of GSK525762 and fulvestrant in women with advanced or metastatic ER+ ...

  3. Iron-Immune System Interaction Shapes Renal Allograft Outcomes After Infections - Mayo Clinic

    About this study. The objectives of this study are to establish the dynamic changes in iron metabolism and circulating iron-regulatory immune cells in ...

  4. HTN App for HTN Control and Cardiovascular Health Among African-Americans - Mayo Clinic

    The purpose of this study is to test the hypertension (HTN) app-based intervention to see if it is more effective in improving uncontrolled HTN and HTN self- ...

  5. Tissue and Blood Registry for Individuals with Liver and Biliary Tumors - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. Study Evaluating the Safety and Effectiveness of JCARH125 in Subjects with Relapsed and/or Refractory Multiple Myeloma (EVOLVE) - Mayo Clinic

    The study will include a Phase 1 part to determine the recommended dose of JCARH125 in subjects with relapsed and/or refractory multiple myeloma, followed by a ...

  7. Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia - Mayo Clinic

    The objective of this study is to assess the safety and tolerability, including the maximum tolerated dose, of ASP2215 in subjects with relapsed or treatment- ...

  8. A Study of the Safety of Using SIC 8000 in Patients Undergoing Endoscopic Mucosal Removal of Colon Lesions Equal to or Larger Than 2 cm - Mayo Clinic

    The purpose of this study is to assess the effectiveness of SIC 8000 injected into the submucosa under polyps, adenomas, early-stage cancers or other ...

  9. Donor-Specific Cell Free DNA Monitoring of Thoracic Allografts - Mayo Clinic

    The purpose of this study is to determine if DNA originating from the transplanted heart or lung can be detected in the blood and used to monitor for rejection.

  10. Message from Campaign Chair-Our Vision Giving to Mayo Clinic

    ... . VID-20093980. Home; Message from Campaign Chair-Our Vision Giving to Mayo Clinic. Double your impact on cancer!